GoodRx Holdings

GDRX

Medical - Healthcare Information Services · Healthcare

Exchange

NASDAQ

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Good

Growth

Weak

Cash Flow

Exceptional

Stability

Mixed

Valuation

Weak

Track this stock — start free trial

Winston Score History

The full picture

GoodRx helps Americans save money on prescription drugs. It runs a website and app where people can search for the lowest price on medications at nearby pharmacies, then get a coupon or discount card to use at checkout. The company sits between patients, pharmacies, and pharmacy benefit managers, and it is one of the most recognized prescription savings brands in the United States.

GoodRx makes money mainly by collecting a fee each time a consumer uses one of its discount codes at a pharmacy. It also earns revenue from pharmaceutical manufacturers who pay to promote their drugs, and from subscription plans that offer deeper savings. The business operates almost entirely in the United States and benefits from strong brand recognition and a large database of pricing data that is hard for newcomers to replicate quickly. The main risk is that pharmacy benefit managers or insurers could change their pricing agreements with GoodRx, which would directly cut into the fees the company collects per prescription filled.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

89.5%

Premium pricing power — 89.5% gross margin

Profit after running costs

Operating Margin

11.8%

Modest — 11.8% operating margin

Return on the money invested

ROCE

7.1%

Weak — 7.1% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-1.8%

Shrinking sales (-1.8% YoY)

Profit growth

EPS YoY

-55.5%

Earnings shrinking (-55.5% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

1313%

Turns 1313% of profit into real cash

Spare cash per sale

FCF Margin

19.9%

Converts sales into free cash efficiently (19.9%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.75

Moderate — manageable debt (0.75)

Covers its interest

Interest Cover

1.97x

Dangerous — barely covers interest (2.0x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

65.6x

no trend

Expensive — P/E 65.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial